Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Polarean Imaging Ltd (POLX) ORD GBP0.00037

Sell:19.00p Buy:21.00p 0 Change: 1.00p (5.26%)
Market closed Prices as at close on 13 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:19.00p
Buy:21.00p
Change: 1.00p (5.26%)
Market closed Prices as at close on 13 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:19.00p
Buy:21.00p
Change: 1.00p (5.26%)
Market closed Prices as at close on 13 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Polarean Imaging Plc is a medical drug-devising company. The Company with its subsidiaries operates in the medical imaging market and develops equipment to enable existing magnetic resonance imaging (MRI) systems. The Company focuses on improving the level of pulmonary functional imaging, and specializing the use of polarised Xenon gas (129Xe) as an imaging agent to visualize ventilation, and gas exchange. The Group also develops and manufactures high performance MRI radiofrequency (RF) coils which are a required for imaging 129Xe in the MRI system. The United States food and drug administration (FDA) has accepted the group’s III clinical trial and design.

Contact details

Address:
2500 Meridian Pkwy Ste 175
DURHAM
27713-4214
United States
Telephone:
+1 (0919) 2067900
Website:
www.polarean.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 24 September 2019 24/09/19
AGM 25 July 2019 25/07/19
Final results 27 June 2019 27/06/19
General meeting 28 December 2018 28/12/18

General stock information

EPIC:
POLX
ISIN:
GB00BF3DT583
Market cap:
£22.89 million
Shares in issue:
114.44 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Richard Hullihen
    Chief Executive Officer, Director
  • Charles Osborne
    Chief Financial Officer
  • Kenneth West
    Chief Operating Officer, Director
  • Bastiaan Driehuys
    Chief Technology Officer
  • Kiarash Emami
    Vice President, Technology and Applications

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.